|
- Homepage | Gut
Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas
- About | Gut
Discover journal metrics, statistics, affiliations and contact information for Gut, a leading international journal in gastroenterology and hepatology
- Gut microbiome and health: mechanistic insights | Gut
The gut microbiota is now considered as one of the key elements contributing to the regulation of host health Virtually all our body sites are colonised by microbes suggesting different types of crosstalk with our organs
- Integration of lipidomics with targeted, single cell, and spatial . . .
Background Over a century ago, Virchow proposed that cancer represents a chronically inflamed, poorly healing wound Normal wound healing is represented by a transitory phase of inflammation, followed by a pro-resolution phase, with prostaglandin (PGE2 PGD2)-induced ‘lipid class switching’ producing inflammation-quenching lipoxins (LXA4, LXB4) Objective We explored if lipid dysregulation
- Authors | Gut
Editorial policies and guidelines for authors seeking to submit to Gut, a leading international journal in gastroenterology and hepatology
- British Society of Gastroenterology guidelines on colorectal . . .
Patients with inflammatory bowel disease (IBD) remain at increased risk for colorectal cancer and death from colorectal cancer compared with the general population despite improvements in inflammation control with advanced therapies, colonoscopic surveillance and reductions in environmental risk factors This guideline update from 2010 for colorectal surveillance of patients over 16 years with
- Construction of exosome non-coding RNA feature for non-invasive, early . . .
Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic methods are lacking Exosome non-coding RNAs (ncRNAs), a type of liquid biopsy, have emerged as promising diagnostic biomarkers for various tumours This study aimed to identify a serum exosome ncRNA feature for enhancing GC diagnosis Designs Serum exosomes from patients
- British Society of Gastroenterology practice guidance on the management . . .
Smoking and low BMI (less than 18 5 kg m 2) predict worse toxicity acutely 72 The gut microbiota appears to be important 73 Predicting late toxicity accurately in the individual patient is still not possible 8 As the severity of acute toxicity predisposes to late toxicity, reduction of acute toxicity should be prioritised
|
|
|